🔗 Share this article

An underground economy for unlicensed slimming medications is propelled by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Followers are encouraged to contact these profiles privately for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where communities with thousands of participants share “before and after” images, injection guides and assertions of next-day UK delivery. Vendors market the drug there before redirecting customers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Express Worries

Nevertheless, doctors and chemists have warned that the sale of what is still an unlicensed drug in the UK is worrisome and could result in users administering products of unknown origin.

Some professionals stated the popularity for retatrutide could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.

Legal Position and Implementation

Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unapproved medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach medicines, advertising, and consumer regulations, risking penalties, prosecution or prison.

Platform Response and Content Removal

Based on TikTok, the service has taken down problematic content and banned associated hashtags and search suggestions. The organization said it was dedicated to maintaining the service safe and allocating resources in strengthening compliance measures.

Digital Marketplace Activities

Investigations also found groups with up to 9,000 participants selling the experimental drug using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly displays channels with thousands of users, populated with photos of weight loss, positive reviews and detailed instructions for mixing or administering at home.

Within minutes of entering one community, a vendor posted WhatsApp details, where the majority of transactions occur. The seller sent an guidebook and promised delivery within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about body mass, health issues or previous experience.

Item Details and Pricing

Within these groups, messages show black plastic packages with Royal Mail stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When questioned how long a injector should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for Telegram said it actively moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering materials they cannot confirm. Although the research behind retatrutide is sound, these online versions may not contain what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are using social media. But fake treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.

Her team has previously encountered patients injured by personal administration from unverified sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company experimental product not yet authorized … may expose users to possibly serious health risks”.